Suppr超能文献

麻醉和死后间隔时间对小鼠大脑中糖原合酶激酶-3的调节性丝氨酸磷酸化有深远影响。

Anesthesia and post-mortem interval profoundly influence the regulatory serine phosphorylation of glycogen synthase kinase-3 in mouse brain.

作者信息

Li Xiaohua, Friedman Ari B, Roh Myoung-Sun, Jope Richard S

机构信息

Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, 1720 7th Avenue South, Birmingham, AL 35294-0017, USA.

出版信息

J Neurochem. 2005 Feb;92(3):701-4. doi: 10.1111/j.1471-4159.2004.02898.x.

Abstract

Glycogen synthase kinase-3 (GSK3) is a crucial enzyme contributing to the regulation of neuronal structure, plasticity and survival, is implicated as a contributory factor in prevalent diseases such as Alzheimer's disease and mood disorders and is regulated by a wide range of signaling systems and pharmacological agents. Therefore, factors regulating GSK3 in vivo are currently of much interest. GSK3 is inhibited by phosphorylation of serine-9 or serine-21 in GSK3beta and GSK3alpha, respectively. This study found that accurate measurements of phospho-Ser-GSK3 in brain are confounded by a rapid post-mortem dephosphorylation, with approximately 90% dephosphorylation of both GSK3 isoforms occurring within 2 min post-mortem. Furthermore, three anesthetics, pentobarbital, halothane and chloral hydrate, each caused large in vivo increases in the serine phosphorylation of both GSK3beta and GSK3alpha in several regions of mouse brain. Thus, studies of the phosphorylation state of GSK3 in brain, and perhaps in other tissues, need to take into account post-mortem changes and the effects of anesthetics and there is a direct correlation between anesthesia and high levels of serine-phosphorylated GSK3.

摘要

糖原合酶激酶-3(GSK3)是一种关键酶,对神经元结构、可塑性和存活的调节起作用,被认为是诸如阿尔茨海默病和情绪障碍等常见疾病的一个促成因素,并且受多种信号系统和药物制剂的调节。因此,目前体内调节GSK3的因素备受关注。GSK3β和GSK3α中丝氨酸-9或丝氨酸-21的磷酸化分别抑制GSK3。本研究发现,脑内磷酸化丝氨酸-GSK3的准确测量受到死后快速去磷酸化的干扰,两种GSK3亚型在死后2分钟内约90%发生去磷酸化。此外,三种麻醉剂,戊巴比妥、氟烷和水合氯醛,各自在小鼠脑的几个区域均引起体内GSK3β和GSK3α丝氨酸磷酸化大幅增加。因此,对脑内以及可能在其他组织中GSK3磷酸化状态的研究需要考虑死后变化以及麻醉剂的影响,并且麻醉与高水平丝氨酸磷酸化GSK3之间存在直接关联。

相似文献

2
Hypoxia activates glycogen synthase kinase-3 in mouse brain in vivo: protection by mood stabilizers and imipramine.
Biol Psychiatry. 2005 Feb 1;57(3):278-86. doi: 10.1016/j.biopsych.2004.10.039.
3
In vivo regulation of GSK3 phosphorylation by cholinergic and NMDA receptors.
Neurobiol Aging. 2006 Mar;27(3):413-22. doi: 10.1016/j.neurobiolaging.2005.03.003. Epub 2005 Apr 26.
4
Blocked inhibitory serine-phosphorylation of glycogen synthase kinase-3alpha/beta impairs in vivo neural precursor cell proliferation.
Biol Psychiatry. 2009 Sep 1;66(5):494-502. doi: 10.1016/j.biopsych.2009.04.015. Epub 2009 Jun 11.
6
Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics.
Int J Neuropsychopharmacol. 2007 Feb;10(1):7-19. doi: 10.1017/S1461145706006547. Epub 2006 May 4.
7
GSK3β isoform-selective regulation of depression, memory and hippocampal cell proliferation.
Genes Brain Behav. 2016 Mar;15(3):348-55. doi: 10.1111/gbb.12283. Epub 2016 Feb 12.
8
Protein levels of glycogen synthase 3 kinase are normal in progressive supranuclear palsy.
Neurosci Lett. 2004 Aug 5;366(1):67-70. doi: 10.1016/j.neulet.2004.05.014.
9
Evidence that glycogen synthase kinase-3 isoforms have distinct substrate preference in the brain.
J Neurochem. 2010 Nov;115(4):974-83. doi: 10.1111/j.1471-4159.2010.06988.x. Epub 2010 Oct 5.

引用本文的文献

1
2
Inhibition of AKT Signaling Alters βIV Spectrin Distribution at the AIS and Increases Neuronal Excitability.
Front Mol Neurosci. 2021 Jun 30;14:643860. doi: 10.3389/fnmol.2021.643860. eCollection 2021.
3
The proteome and its dynamics: A missing piece for integrative multi-omics in schizophrenia.
Schizophr Res. 2020 Mar;217:148-161. doi: 10.1016/j.schres.2019.07.025. Epub 2019 Aug 13.
5
Comparing the proteome of snap frozen, RNAlater preserved, and formalin-fixed paraffin-embedded human tissue samples.
EuPA Open Proteom. 2015 Nov 2;10:9-18. doi: 10.1016/j.euprot.2015.10.001. eCollection 2016 Mar.
9
Individual Case Analysis of Postmortem Interval Time on Brain Tissue Preservation.
PLoS One. 2016 Mar 16;11(3):e0151615. doi: 10.1371/journal.pone.0151615. eCollection 2016.
10

本文引用的文献

1
The glamour and gloom of glycogen synthase kinase-3.
Trends Biochem Sci. 2004 Feb;29(2):95-102. doi: 10.1016/j.tibs.2003.12.004.
2
Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade.
Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):5099-104. doi: 10.1073/pnas.0307921101. Epub 2004 Mar 24.
3
In vivo regulation of glycogen synthase kinase-3beta (GSK3beta) by serotonergic activity in mouse brain.
Neuropsychopharmacology. 2004 Aug;29(8):1426-31. doi: 10.1038/sj.npp.1300439.
4
Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia.
Nat Genet. 2004 Feb;36(2):131-7. doi: 10.1038/ng1296. Epub 2004 Jan 25.
5
Diverse psychotomimetics act through a common signaling pathway.
Science. 2003 Nov 21;302(5649):1412-5. doi: 10.1126/science.1089681.
6
Prenatal cocaine exposure alters glycogen synthase kinase-3beta (GSK3beta) pathway in select rabbit brain areas.
Neurosci Lett. 2003 Oct 9;349(3):143-6. doi: 10.1016/s0304-3940(03)00852-8.
7
Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium.
Neuropharmacology. 2002 Dec;43(7):1158-64. doi: 10.1016/s0028-3908(02)00215-0.
8
Glycogen synthase kinase 3: an emerging therapeutic target.
Trends Mol Med. 2002 Mar;8(3):126-32. doi: 10.1016/s1471-4914(01)02266-3.
9
GSK-3 and the neurodevelopmental hypothesis of schizophrenia.
Eur Neuropsychopharmacol. 2002 Feb;12(1):13-25. doi: 10.1016/s0924-977x(01)00131-6.
10
Glycogen synthase kinase-3: properties, functions, and regulation.
Chem Rev. 2001 Aug;101(8):2527-40. doi: 10.1021/cr000110o.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验